LINC00641: A Long Intergenic Non-Protein Coding RNA (G283624)

Target Name: LINC00641

NCBI ID: G283624

LINC00641

Other Name(s): long intergenic non-protein coding RNA 641 | Long intergenic non-protein coding RNA 641, transcript variant 1

LINC00641: A Long Intergenic Non-Protein Coding RNA

LINC00641 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its unique structure, which consists of multiple exons originating from different genomic regions. This unique feature has led to the conclusion that LINC00641 may have a novel function in gene regulation. Although the precise function of LINC00641 remains elusive, its potential as a drug target or biomarker is of great interest.

Structure and Expression

LINC00641 is a 292-nt RNA molecule with a unique 5' end that contains a poly(A) tail. It was identified by bioinformatic analysis of RNA sequencing data and has been shown to have a higher expression level than other lncRNAs in various organisms, including human samples.

The structure of LINC00641 is unique as well. It consists of multiple exons originating from different genomic regions, including genomic regions that are highly conserved across various organisms. This suggests that LINC00641 may have a functional role in gene regulation by modulating gene expression levels.

Function and Potential Therapies

The function of LINC00641 is still being explored, but several potential therapeutic applications have been identified. One of the most promising targets for LINC00641 is the regulation of cell adhesion, which is critical for various physiological processes, including tissue repair and regeneration.

LINC00641 has been shown to be involved in the regulation of cell adhesion in various organisms, including humans. Studies have shown that LINC00641 is a negative regulator of the adherens junction, a critical structure that connects cells and is involved in various physiological processes, including tissue repair and regeneration.

In addition to its role in cell adhesion, LINC00641 has also been shown to be involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the regulation of cell growth, differentiation, and survival, and is a potential target for various therapeutic applications.

LINC00641 has also been shown to be involved in the regulation of stem cell biology, which is critical for the development and maintenance of various tissues and organs. This suggests that LINC00641 may have a potential therapeutic application in the treatment of diseases that involve stem cell dysfunction, such as cancer.

Conclusion

In conclusion, LINC00641 is a unique and highly expressed lncRNA that has been identified in various organisms, including humans. Its unique structure and function make it a potential drug target or biomarker. Further research is needed to fully understand the role of LINC00641 in gene regulation and its potential therapeutic applications.

Protein Name: Long Intergenic Non-protein Coding RNA 641

The "LINC00641 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00641 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets